You're steps away from the future of investing.
Investing in commercial legal claims is a new way to diversify your portfolio.
Get Started
What are the benefits of investing in litigation finance assets?
Historical Performance
Resolved case investments have generated a median 47% net annualized return to investors as of August 31, 2020.
Uncorrelated Asset
Legal claims are largely uncorrelated to broader market conditions and macroeconomic activity.
Moderate Durations
On average, a civil lawsuit in the United States takes 27 months from filing to disposition.
Institutional Strategy
Harvard's endowment, sovereign wealth funds and leading institutions all have made investments in litigation finance.
Out of the thousands of prospective litigation funding opportunities reviewed by our veteran underwriting team, less than 5% are approved for investment, yielding strong results.
Past performance is not indicative of future performance. Returns are based on principal's internal reporting for offerings through the LexShares platform reaching resolution as of August 31, 2020. Results reported reflect the simple median annualized rate of return per the xirr function, net of fees and expenses. Diversification does not guarantee profits or protect against losses
Open investments
LexShares Marketplace Fund II
$100M
Marketplace Fund
LexShares Marketplace Fund II (LMFII) enables investors to gain exposure to multiple litigation finance assets through one investment vehicle.
The LexShares process
Plaintiffs are eligible to submit claims directly for review.
1
Apply
Submit your application for funding and execute NDA.
2
Review
LexShares' team reviews your case.
3
Approve
LexShares sends a contract detailing terms of funding.
4
Fund
Contract executed and funding deployed.
Some of our recent investments
LexShares invests in a wide range of litigation finance assets, from single commercial matters, to portfolios, to direct law firm fundings. Below is a look at some recently funded deals, or you can view all of our case investments here.
- Shareholders vs.
Company100% Funded$2.00MClosedFraudDefendants allegedly defrauded plaintiffs, squeezing them out of their equity interest in the company. - Confidential plaintiffs vs.
Confidential defendants100% Funded$4.00MClosedLaw Firm FundingThis is a law firm funding collateralized by a portfolio of cases in the pharmaceutical industry. - Confidential Plaintiff vs.
Confidential Defendant100% Funded$750KClosedBreach of ContractThis is a breach of contract case regarding division of property and valuation of stock options. - Confidential Plaintiff vs.
Government Entity100% Funded$475KClosedBreach of Fiduciary DutyPlaintiff alleges that Government Entity, in its capacity as trustee, breached duties to plaintiff by mismanaging plaintiff's assets. - Engineering Firm vs.
Manufacturer100% Funded$2.00MClosedBreach of ContractDefendant allegedly breached agreements with plaintiffs by failing to pay contractual royalties due and misappropriating plaintiffs' trade secrets. - Investor vs.
Finance Company100% Funded$1.13MClosedBreach of ContractDefendants allegedly failed to repay certain proceeds owed to Plaintiff relating to investments in Defendants’ business. - Real Estate Developer vs.
Business Partner100% Funded$3.50MResolvedSettlementThis is a settlement acceleration related to a number of real estate disputes with a negotiated and executed settlement. - Acquiror vs.
Seller100% Funded$750KClosedBreach of ContractIn a claim related to a business acquisition, defendants allegedly fraudulently induced plaintiffs to purchase their company. - Technology Company vs.
Fortune 500 Company100% Funded$1.20MClosedPatent InfringementDefendant allegedly infringed on Plaintiff's registered patent without authorization. - Shareholders vs.
Company100% Funded$2.00MClosedFraudDefendants allegedly defrauded plaintiffs, squeezing them out of their equity interest in the company. - Confidential plaintiffs vs.
Confidential defendants100% Funded$4.00MClosedLaw Firm FundingThis is a law firm funding collateralized by a portfolio of cases in the pharmaceutical industry. - Confidential Plaintiff vs.
Confidential Defendant100% Funded$750KClosedBreach of ContractThis is a breach of contract case regarding division of property and valuation of stock options. - Confidential Plaintiff vs.
Government Entity100% Funded$475KClosedBreach of Fiduciary DutyPlaintiff alleges that Government Entity, in its capacity as trustee, breached duties to plaintiff by mismanaging plaintiff's assets. - Engineering Firm vs.
Manufacturer100% Funded$2.00MClosedBreach of ContractDefendant allegedly breached agreements with plaintiffs by failing to pay contractual royalties due and misappropriating plaintiffs' trade secrets. - Investor vs.
Finance Company100% Funded$1.13MClosedBreach of ContractDefendants allegedly failed to repay certain proceeds owed to Plaintiff relating to investments in Defendants’ business. - Real Estate Developer vs.
Business Partner100% Funded$3.50MResolvedSettlementThis is a settlement acceleration related to a number of real estate disputes with a negotiated and executed settlement. - Acquiror vs.
Seller100% Funded$750KClosedBreach of ContractIn a claim related to a business acquisition, defendants allegedly fraudulently induced plaintiffs to purchase their company. - Technology Company vs.
Fortune 500 Company100% Funded$1.20MClosedPatent InfringementDefendant allegedly infringed on Plaintiff's registered patent without authorization. - Shareholders vs.
Company100% Funded$2.00MClosedFraudDefendants allegedly defrauded plaintiffs, squeezing them out of their equity interest in the company. - Confidential plaintiffs vs.
Confidential defendants100% Funded$4.00MClosedLaw Firm FundingThis is a law firm funding collateralized by a portfolio of cases in the pharmaceutical industry. - Confidential Plaintiff vs.
Confidential Defendant100% Funded$750KClosedBreach of ContractThis is a breach of contract case regarding division of property and valuation of stock options. - Confidential Plaintiff vs.
Government Entity100% Funded$475KClosedBreach of Fiduciary DutyPlaintiff alleges that Government Entity, in its capacity as trustee, breached duties to plaintiff by mismanaging plaintiff's assets. - Engineering Firm vs.
Manufacturer100% Funded$2.00MClosedBreach of ContractDefendant allegedly breached agreements with plaintiffs by failing to pay contractual royalties due and misappropriating plaintiffs' trade secrets. - Investor vs.
Finance Company100% Funded$1.13MClosedBreach of ContractDefendants allegedly failed to repay certain proceeds owed to Plaintiff relating to investments in Defendants’ business. - Real Estate Developer vs.
Business Partner100% Funded$3.50MResolvedSettlementThis is a settlement acceleration related to a number of real estate disputes with a negotiated and executed settlement. - Acquiror vs.
Seller100% Funded$750KClosedBreach of ContractIn a claim related to a business acquisition, defendants allegedly fraudulently induced plaintiffs to purchase their company. - Technology Company vs.
Fortune 500 Company100% Funded$1.20MClosedPatent InfringementDefendant allegedly infringed on Plaintiff's registered patent without authorization. - Shareholders vs.
Company100% Funded$2.00MClosedFraudDefendants allegedly defrauded plaintiffs, squeezing them out of their equity interest in the company. - Confidential plaintiffs vs.
Confidential defendants100% Funded$4.00MClosedLaw Firm FundingThis is a law firm funding collateralized by a portfolio of cases in the pharmaceutical industry. - Confidential Plaintiff vs.
Confidential Defendant100% Funded$750KClosedBreach of ContractThis is a breach of contract case regarding division of property and valuation of stock options. - Confidential Plaintiff vs.
Government Entity100% Funded$475KClosedBreach of Fiduciary DutyPlaintiff alleges that Government Entity, in its capacity as trustee, breached duties to plaintiff by mismanaging plaintiff's assets. - Engineering Firm vs.
Manufacturer100% Funded$2.00MClosedBreach of ContractDefendant allegedly breached agreements with plaintiffs by failing to pay contractual royalties due and misappropriating plaintiffs' trade secrets. - Investor vs.
Finance Company100% Funded$1.13MClosedBreach of ContractDefendants allegedly failed to repay certain proceeds owed to Plaintiff relating to investments in Defendants’ business. - Real Estate Developer vs.
Business Partner100% Funded$3.50MResolvedSettlementThis is a settlement acceleration related to a number of real estate disputes with a negotiated and executed settlement. - Acquiror vs.
Seller100% Funded$750KClosedBreach of ContractIn a claim related to a business acquisition, defendants allegedly fraudulently induced plaintiffs to purchase their company. - Technology Company vs.
Fortune 500 Company100% Funded$1.20MClosedPatent InfringementDefendant allegedly infringed on Plaintiff's registered patent without authorization. - Shareholders vs.
Company100% Funded$2.00MClosedFraudDefendants allegedly defrauded plaintiffs, squeezing them out of their equity interest in the company. - Confidential plaintiffs vs.
Confidential defendants100% Funded$4.00MClosedLaw Firm FundingThis is a law firm funding collateralized by a portfolio of cases in the pharmaceutical industry. - Confidential Plaintiff vs.
Confidential Defendant100% Funded$750KClosedBreach of ContractThis is a breach of contract case regarding division of property and valuation of stock options. - Confidential Plaintiff vs.
Government Entity100% Funded$475KClosedBreach of Fiduciary DutyPlaintiff alleges that Government Entity, in its capacity as trustee, breached duties to plaintiff by mismanaging plaintiff's assets. - Engineering Firm vs.
Manufacturer100% Funded$2.00MClosedBreach of ContractDefendant allegedly breached agreements with plaintiffs by failing to pay contractual royalties due and misappropriating plaintiffs' trade secrets. - Investor vs.
Finance Company100% Funded$1.13MClosedBreach of ContractDefendants allegedly failed to repay certain proceeds owed to Plaintiff relating to investments in Defendants’ business. - Real Estate Developer vs.
Business Partner100% Funded$3.50MResolvedSettlementThis is a settlement acceleration related to a number of real estate disputes with a negotiated and executed settlement. - Acquiror vs.
Seller100% Funded$750KClosedBreach of ContractIn a claim related to a business acquisition, defendants allegedly fraudulently induced plaintiffs to purchase their company. - Technology Company vs.
Fortune 500 Company100% Funded$1.20MClosedPatent InfringementDefendant allegedly infringed on Plaintiff's registered patent without authorization. - Shareholders vs.
Company100% Funded$2.00MClosedFraudDefendants allegedly defrauded plaintiffs, squeezing them out of their equity interest in the company. - Confidential plaintiffs vs.
Confidential defendants100% Funded$4.00MClosedLaw Firm FundingThis is a law firm funding collateralized by a portfolio of cases in the pharmaceutical industry. - Confidential Plaintiff vs.
Confidential Defendant100% Funded$750KClosedBreach of ContractThis is a breach of contract case regarding division of property and valuation of stock options. - Confidential Plaintiff vs.
Government Entity100% Funded$475KClosedBreach of Fiduciary DutyPlaintiff alleges that Government Entity, in its capacity as trustee, breached duties to plaintiff by mismanaging plaintiff's assets. - Engineering Firm vs.
Manufacturer100% Funded$2.00MClosedBreach of ContractDefendant allegedly breached agreements with plaintiffs by failing to pay contractual royalties due and misappropriating plaintiffs' trade secrets. - Investor vs.
Finance Company100% Funded$1.13MClosedBreach of ContractDefendants allegedly failed to repay certain proceeds owed to Plaintiff relating to investments in Defendants’ business. - Real Estate Developer vs.
Business Partner100% Funded$3.50MResolvedSettlementThis is a settlement acceleration related to a number of real estate disputes with a negotiated and executed settlement. - Acquiror vs.
Seller100% Funded$750KClosedBreach of ContractIn a claim related to a business acquisition, defendants allegedly fraudulently induced plaintiffs to purchase their company. - Technology Company vs.
Fortune 500 Company100% Funded$1.20MClosedPatent InfringementDefendant allegedly infringed on Plaintiff's registered patent without authorization. - Shareholders vs.
Company100% Funded$2.00MClosedFraudDefendants allegedly defrauded plaintiffs, squeezing them out of their equity interest in the company. - Confidential plaintiffs vs.
Confidential defendants100% Funded$4.00MClosedLaw Firm FundingThis is a law firm funding collateralized by a portfolio of cases in the pharmaceutical industry. - Confidential Plaintiff vs.
Confidential Defendant100% Funded$750KClosedBreach of ContractThis is a breach of contract case regarding division of property and valuation of stock options. - Confidential Plaintiff vs.
Government Entity100% Funded$475KClosedBreach of Fiduciary DutyPlaintiff alleges that Government Entity, in its capacity as trustee, breached duties to plaintiff by mismanaging plaintiff's assets. - Engineering Firm vs.
Manufacturer100% Funded$2.00MClosedBreach of ContractDefendant allegedly breached agreements with plaintiffs by failing to pay contractual royalties due and misappropriating plaintiffs' trade secrets. - Investor vs.
Finance Company100% Funded$1.13MClosedBreach of ContractDefendants allegedly failed to repay certain proceeds owed to Plaintiff relating to investments in Defendants’ business. - Real Estate Developer vs.
Business Partner100% Funded$3.50MResolvedSettlementThis is a settlement acceleration related to a number of real estate disputes with a negotiated and executed settlement. - Acquiror vs.
Seller100% Funded$750KClosedBreach of ContractIn a claim related to a business acquisition, defendants allegedly fraudulently induced plaintiffs to purchase their company. - Technology Company vs.
Fortune 500 Company100% Funded$1.20MClosedPatent InfringementDefendant allegedly infringed on Plaintiff's registered patent without authorization.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
How we invest.
LexShares uses a multi-channel investment approach to ensure speed and certainty of funds.
LexShares Marketplace Fund
In June 2020, LexShares launched its second privately managed fund, a $100 million fully discretionary litigation finance fund that gets deployed into each legal investment made by LexShares.
LexShares Funding Platform
LexShares operates an online platform that enables institutional and individual accredited investors to participate in certain funding opportunities. Offerings are typically fully funded by LexShares prior to being made available to investors.
Request our litigation finance guide.
LexShares' comprehensive guide provides in-depth coverage of the litigation finance industry.
